Related Experiment Video
Updated: Aug 7, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Bax conformational change is a crucial step for PUMA-mediated apoptosis in human leukemia
Feng-Ting Liu1, Adrian C Newland, Li Jia
1Department of Haematology, Barts and the London, Queen Mary's School of Medicine and Dentistry, University of London, London, UK.
Abstract:
The BH3-only protein, PUMA, plays an important role in p53-mediated apoptosis. The apoptotic effect of PUMA on the mitochondria was studied using a p53-negative, human leukemia K562 cell line. Overexpression of PUMA was accompanied by an increased Bax expression, Bax conformational change, and translocation to mitochondria. A PUMA-BH3 peptide can induce Bax conformational change, cytochrome c release, and reduction in the mitochondrial membrane potential (DeltaPsi(m)) in isolated K562 mitochondria and can be inhibited by Bcl-XL. The homo-dimer of Bax/Bax was also weakly shown after mitochondria were treated with PUMA-BH3 peptide but may not be lethal for PUMA-induced apoptosis in K562 cells. Our results suggest that PUMA-induced Bax conformational change and Bax translocation to mitochondria can be separate events and the conformational change in Bax is crucial for PUMA-induced mitochondrial dysfunction.
Insights
The BH3-only protein PUMA triggers apoptosis by altering the Bax protein
Area of Science:
- Cellular and Molecular Biology
- Cancer Research
- Apoptosis Signaling
Background:
- PUMA is a key mediator of p53-induced apoptosis.
- Understanding PUMA's role in apoptosis is crucial for cancer therapy.
- Mitochondrial apoptosis pathways are critical in cell death regulation.
Purpose of the Study:
- To investigate the specific mechanisms by which PUMA induces apoptosis in leukemia cells.
- To determine the role of Bax protein conformational changes and mitochondrial translocation in PUMA-mediated apoptosis.
- To elucidate the direct effects of PUMA on mitochondrial function.
Main Methods:
- Utilized a p53-negative human leukemia K562 cell line.
- Studied the effects of PUMA overexpression and PUMA-BH3 peptide treatment.
- Analyzed Bax expression, conformational changes, and mitochondrial translocation.
- Assessed cytochrome c release and mitochondrial membrane potential (ΔΨm).
- Investigated the role of Bcl-XL as an inhibitor.
Main Results:
- PUMA overexpression led to increased Bax expression, conformational changes, and mitochondrial translocation.
- PUMA-BH3 peptide induced Bax conformational change, cytochrome c release, and reduced mitochondrial membrane potential in isolated mitochondria.
- Bcl-XL inhibited PUMA-BH3 peptide-induced mitochondrial dysfunction.
- Bax homo-dimerization was weakly observed but not essential for PUMA-induced apoptosis.
Conclusions:
- PUMA-induced Bax conformational change and mitochondrial translocation are distinct events.
- Bax conformational change is critical for PUMA-mediated mitochondrial dysfunction and apoptosis.
- PUMA directly impacts mitochondrial integrity, leading to cell death.
Related Concept Videos
Abnormal Proliferation
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy

